适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
1 期
Bioequivalence of Amoxicillin and Clavulanic Acid 875 mg/125 mg Film-Coated Tablets in Healthy Participants Under Fed Conditions.o medical condition.CTIS2024-513752-15-00Bial Portela & Ca S.A.48
进行中（未招募）
1 期
Bioequivalence of Amoxicillin and Clavulanic Acid 500 mg/125 mg Film-Coated Tablets in Healthy Participants Under Fed Conditions.o medical condition.CTIS2024-513751-32-00Bial Portela & Ca S.A.48
进行中（未招募）
1 期
Comparative Bioavailability of Nilotinib 200 mg Hard Capsules in Healthy Subjects.Primary Philadelphia-chromosome positive leukemia cells from chronic myelogenous leukemia (CML)MedDRA version: 22.0Level: LLTClassification code: 10082180Term: Philadelphia positive chronic myeloid leukaemia Class: 10029104CTIS2022-501325-20-00Bluepharma Industria Farmaceutica S.A.20
进行中（未招募）
1 期
Bioequivalence of Betis®10 mg Film-Coated Tablets versus Clozan 10 mg tablets in Healthy Subjectso medical condition.CTIS2023-504901-34-00Synthon Chile LTDA.30
进行中（未招募）
1 期
A SINGLE-CENTER, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO ASSESS SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF REPEAT DOSES OF ARM210 IN HEALTHY SUBJECTS.Cardiac arrhythmiasMedDRA version: 20.0Level: HLGTClassification code: 10007521Term: Cardiac arrhythmias Class: 10007541CTIS2023-509086-20-00Armgo Pharma Inc.8